Luca Boldrini

Università Cattolica del Sacro Cuore, Roma, Italia

Luca Boldrini obtained his Medical Degree and completed his residency program in Radiotherapy at the Università Cattolica del Sacro Cuore of Rome, Italy. 

He currently works as Radiation Oncologist at the Fondazione Policlinico Universitario “A. Gemelli” IRCCS - Università Cattolica del Sacro Cuore of Rome, where he is involved in the MRI guided radiotherapy research program.

His primary research interests include MRI guided radiotherapy, radiomics, imaging applications in the frame of personalised medicine and innovative technologies implementation in cancer care.

He is author of numerous scientific publication, books, and e-publications. 
He is clinical coordinator of the radiomics research program of the Knowledge Based Oncology Lab (KBO Lab) of Rome, Italy.

He is currently a Ph.D. student in Oncological Sciences focusing on “Radiation Oncology, imaging and technological innovation” at the Università Cattolica del Sacro Cuore of Rome, Italy and member of several national and
international scientific associations.

dont miss

Radiomics applications rectal cancer: the MRIdian perspective

The seminar will describe the potentialities of low T MRI guided hybrid Radiotherapy from a radiomics perspective. The talk will be focused on radiomics based prediction models for complete clinical response in rectal cancer patients undergoing neoadjuvant chemoradiotherapy.

EVEN MORE SEMINARS

  • Professor Anthony Howell: Speaking at the Oncology Convention

    Professor Anthony Howell
    The University of Manchester / The Christie NHS Foundation Trust

    Improving risk estimation of breast cancer

  • Dr Catherine Coyle: Speaking at the Oncology Convention

    Dr Catherine Coyle
    Christie Hospital NHS Foundation Trust

    Prostate Cancer- the non surgical oncologists view

  • Dr Khurum Khan: Speaking at the Oncology Convention

    Dr Khurum Khan
    University College London Hospitals

    Translational research in GI Oncology- how to make progress?

  • Dr Abeer Shabaan: Speaking at the Oncology Convention

    Dr Abeer Shabaan
    Queen Elizabeth Hospital Birmingham & University of Birmingham

    Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations

  • Dr Qamar Ghafoor: Speaking at the Oncology Convention

    Dr Qamar Ghafoor
    University Hospital Birmingham

    Stereotactive Radiotherapy Treatment for Primary Lung Cancers, and Oligometastasis to the Lungs.